EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFRC797S Mutation in Non-Small Cell Lung Cancer

Mengxuan Wang, Zhenhong Xia, Wenyan Nie, Chunlong Wang, Haoran Nie, Shuai Zhang, Jiaqi Qiu, Yang Yang, Cuifang Yao, Ling Xu, Baijiao An

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s490303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Mengxuan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, Shandong, P…. Hauptthemen laut MEDLINE: Sulfonamides, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesCarcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsDrug DesignProtein Kinase InhibitorsCyclopropanesHumansErbB ReceptorsCell ProliferationDrug Screening Assays, AntitumorApoptosisMutationStructure-Activity RelationshipMiceMolecular StructureDose-Response Relationship, DrugAnimalsMolecular Docking SimulationCell Line, TumorMice, NudeTumor Cells, CulturedNeoplasms, Experimental

Stichwörter der Autor:innen

EGFR C797S mutationEGFR-TKIsNSCLCbiological activity

Substanzen

SulfonamidesErbB ReceptorsAntineoplastic AgentsEGFR protein, humanProtein Kinase InhibitorsCyclopropanes

Autor:innen und Institutionen

  • Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, Shandong, People's Republic of China.
  • Department of Respiratory Critical Care Medicine, Binzhou Medical University Hospital, Yantai, Shandong, People's Republic of China.

Zitieren

APA

Wang, M., Xia, Z., Nie, W., Wang, C., Nie, H., Zhang, S., Qiu, J., Yang, Y., Yao, C., Xu, L., & An, B. (2025). Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFRC797S Mutation in Non-Small Cell Lung Cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s490303

Vancouver

Wang M, Xia Z, Nie W, Wang C, Nie H, Zhang S, et al. Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFRC797S Mutation in Non-Small Cell Lung Cancer. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s490303

BibTeX
@article{Wang2025,
  author = {Wang, Mengxuan and Xia, Zhenhong and Nie, Wenyan and Wang, Chunlong and Nie, Haoran and Zhang, Shuai and Qiu, Jiaqi and Yang, Yang and Yao, Cuifang and Xu, Ling and An, Baijiao},
  title = {Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFRC797S Mutation in Non-Small Cell Lung Cancer},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s490303}
}
Kostenlos starten →